Genomic Expression’s technology takes the guesswork out of the process of developing personal diagnostics which guide the physician in identifying which drug would be most effective for any given individual patient. The kit and software can be used on any of the instruments already in the labs.
We want to save lives and make healthcare delivery more efficient. Today 90% of drugs are only effective in 30-50% of the population. With global drug sales reaching $825 Billion, an estimated $352 Billion is wasted on ineffective drugs. We can change that AND save lives.
We are involved in a number of projects developing new prognostics utilizing access to samples in a single payer system that implemented electronic medical records a decade ago.
Access to historic biological samples is a pre-requisite in the development of next generation diagnostic.
We are interested in entering into collaborations advancing next generation diagnostics to the benefit of patients.
We have assembled a great team with proven track record in genomics, oncology, fundraising, technologies and business development.
The company has advanced its technology through significant non-dilute grants from the Danish Fund for Advanced Technologies.
The company recently closed it's first investment round
Our bait free taget selection kit and software is applicable for highly complex and quantitative genomic analysis of e.g. the RNA's in the cell.
The RNA contain a snapshot of the health condition of the cell.
The kit fits into the existing workflow, can be automated and works with all existing and new instrumentation platforms.